Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tea tree oil

This article was originally published in The Tan Sheet

Executive Summary

FDA tells Rural Industries Research & Development Corporation in February that the agency's review of submissions supporting the use of tea tree oil as a first-aid antiseptic are "not currently in our near-term work plans." FDA said it hopes to complete review of submissions "by the end of this year." RIRDC made a submission to the agency on tea tree oil on behalf of the Australian Tea Tree Industry Association

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082541

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel